Lanreotide Prolonged Release (PR)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lanreotide Prolonged Release (PR), covering 2018-12-14 to 2018-12-14. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly [Phase 3]